SPY411.49+2.97 0.73%
DIA337.86+2.73 0.81%
IXIC13,900.19+70.88 0.51%

BRIEF-Ipsen Biopharmaceuticals Canada Reports Commercial Availability Of Increlex

· 03/16/2021 09:03
BRIEF-Ipsen Biopharmaceuticals Canada Reports Commercial Availability Of Increlex

- Ipsen SA IPN.PA:

  • IPSEN BIOPHARMACEUTICALS CANADA - ANNOUNCED COMMERCIAL AVAILABILITY OF INCRELEX FOR TREATMENT OF GROWTH FAILURE IN CHILDREN & ADOLESCENTS

Source text for Eikon: ID:nCNWjHYpCa

Further company coverage: IPN.PA


((Reuters.Briefs@thomsonreuters.com;))